⌘K

Home/Filings/4/0001225208-15-005985

4//SEC Filing

WEST PHARMACEUTICAL SERVICES INC 4

Accession 0001225208-15-005985

$WSTCIK 0000105770operating

View on SEC.gov Company Profile

Filed

Feb 25, 7:00 PM ET

Accepted

Feb 26, 3:58 PM ET

Size

22.9 KB

Accession

0001225208-15-005985

Insider Transaction Report

Form 4

Period: 2015-02-24

WEST PHARMACEUTICAL SERVICES INCWST

Bedwell Warwick

VP Pharma Pkgs Systems Asia Pa

Transactions

Sale
Common Stock
2015-02-24$52.73/sh−6,584$347,160→ 54,441.38 total
Exercise/Conversion
Common Stock
2015-02-24$20.43/sh+8,562$174,879→ 54,441.38 total
Exercise/Conversion
Common Stock
2015-02-24$47.34/sh+3,617$171,229→ 64,642.38 total
Sale
Common Stock
2015-02-24$53.65/sh−3,617$194,052→ 61,025.38 total
Sale
Common Stock
2015-02-24$53.00/sh−8,562$453,781→ 45,879.38 total
Sale
Common Stock
2015-02-24$52.73/sh−9,458$498,700→ 36,421.38 total
Exercise/Conversion
Stock Option (Right to Buy)
2015-02-24$29.55/sh−6,584$194,590→ 13,168 total
Exercise: $29.55From: 2014-02-19Exp: 2023-02-19→ Common Stock (6,584 underlying)
Exercise/Conversion
Common Stock
2015-02-24$21.22/sh+9,458$200,699→ 45,879.38 total
Exercise/Conversion
Common Stock
2015-02-24$29.55/sh+6,584$194,590→ 61,025.38 total
Exercise/Conversion
Stock Option (Right to Buy)
2015-02-24$21.22/sh−9,458$200,699→ 9,458 total
Exercise: $21.22From: 2013-02-21Exp: 2022-02-21→ Common Stock (9,458 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2015-02-24$20.43/sh−8,562$174,879→ 0 total
Exercise: $20.43From: 2012-02-22Exp: 2021-02-22→ Common Stock (8,562 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2015-02-24$47.34/sh−3,617$171,229→ 10,848 total
Exercise: $47.34From: 2015-02-24Exp: 2024-02-24→ Common Stock (3,617 underlying)

Footnotes (2)

[F1]This was multiple transactions on the same date with prices in the range of $51.905 to $53.65. The undersigned hereby undertakes to provide upon request to the Securities and Exchange Commission, the issuer or any security holder of the issuer on request, full information regarding the number of shares purchased or sold at each separate price.
[F2]This was multiple 51.95 to $53.65. The undersigned hereby undertakes to provide upon request to the Securities and Exchange Commission, the issuer or any security holder of the issuer on request, full information regarding the number of shares purchased or sold at each separate price.

Documents

1 file

4
doc4.xmlPrimary

Issuer

WEST PHARMACEUTICAL SERVICES INC

CIK 0000105770

Entity typeoperating

IncorporatedPA

Related Parties

1

filerCIK 0000105770

Filing Metadata

Form type: 4
Filed: Feb 25, 7:00 PM ET
Accepted: Feb 26, 3:58 PM ET
Size: 22.9 KB

View on SEC.gov